Microsoft Word - 0_Florence_Masterclass_2017_Programme

1060-1061 / 1152

6
Potential of BT in prostate cancer
 ASCENDE-RT
 Randomised
 High and intermediate risk
prostate cancer
 398 pts
 Arm 1: Pelvic 46Gy EBRT +
EBRT boost to 78Gy
 Arm 2: Pelvic 46Gy EBRT +
LDR boost
All patients Intermediate risk
High risk Overall survival
Morris et al, IJROBP, 98(2), 275-285, 2017